Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy

Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol

(2017) Wen-juan Wei et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model

(2017) Xuejiu Cai et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity

(2017) Justin R. Lenhard et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Light Modulates Metabolic Pathways and Other Novel Physiological Traits in the Human Pathogen Acinetobacter baumannii

(2017) Gabriela L. Müller et al.   JOURNAL OF BACTERIOLOGY

Contribution of EmrAB efflux pumps to colistin resistance in Acinetobacter baumannii

(2017) Ming-Feng Lin et al.   JOURNAL OF MICROBIOLOGY

Antimicrobial activity of photodynamic therapy in combination with colistin against a pan-drug resistant Acinetobacter baumannii isolated from burn patient

(2017) Ebrahim Boluki et al.   Photodiagnosis and Photodynamic Therapy

Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii

(2017) Spencer Lee et al.   PHYTOMEDICINE

The Secrets of Acinetobacter Secretion

(2017) Brent S. Weber et al.   TRENDS IN MICROBIOLOGY

Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumannii

(2017) Mohd Hafidz Mahamad Maifiah et al.   Scientific Reports

Assessment of early combination effects of colistin and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii in dynamic time-kill experiments

(2017) Thomas Tängdén et al.   Infectious Diseases

In VitroBactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates

(2016) Martha Nepka et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroSynergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii

(2016) Seongman Bae et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Novel Aminoglycoside Resistance Transposons and Transposon-Derived Circular Forms Detected in Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates

(2016) Nabil Karah et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VivoandIn VitroEfficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii

(2016) Ya-Sung Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii

(2016) Mariana Pagano et al.   BRAZILIAN JOURNAL OF MICROBIOLOGY

Effects of silver nanoparticles in combination with antibiotics on the resistant bacteria Acinetobacter baumannii

(2016) Guoqing Wan et al.   International Journal of Nanomedicine

Synergistic interactions between doxycycline and terpenic components of essential oils encapsulated within lipid nanocapsules against gram negative bacteria

(2016) C. Valcourt et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Antimicrobial activity of Eucalyptus camaldulensis essential oils and their interactions with conventional antimicrobial agents against multi-drug resistant Acinetobacter baumannii

(2016) Petar Knezevic et al.   JOURNAL OF ETHNOPHARMACOLOGY

Class 1 integrons in non-clonal multidrug-resistant Acinetobacter baumannii from Iran, description of the new bla IMP-55 allele in In1243

(2016) Omid Azizi et al.   JOURNAL OF MEDICAL MICROBIOLOGY

In vivo protein interaction network analysis reveals porin-localized antibiotic inactivation in Acinetobacter baumannii strain AB5075

(2016) Xia Wu et al.   Nature Communications

Carbapenem Resistance in Acinetobacter baumannii and Other Acinetobacter spp. Causing Neonatal Sepsis: Focus on NDM-1 and Its Linkage to ISAba125

(2016) Somdatta Chatterjee et al.   Frontiers in Microbiology

Enhanced Antibacterial Activity of Acinetobacter baumannii Bacteriophage ØABP-01 Endolysin (LysABP-01) in Combination with Colistin

(2016) Rapee Thummeepak et al.   Frontiers in Microbiology

Synergistic and Additive Effect of Oregano Essential Oil and Biological Silver Nanoparticles against Multidrug-Resistant Bacterial Strains

(2016) Sara Scandorieiro et al.   Frontiers in Microbiology

Antimicrobial action of zinc oxide nanoparticles in combination with ciprofloxacin and ceftazidime against multidrug-resistant Acinetobacter baumannii

(2016) F. Ghasemi et al.   Journal of Global Antimicrobial Resistance

Structural and Biochemical Characterization of Acinetobacter spp. Aminoglycoside Acetyltransferases Highlights Functional and Evolutionary Variation among Antibiotic Resistance Enzymes

(2016) Peter J. Stogios et al.   ACS Infectious Diseases

Endogenous hydrogen peroxide increases biofilm formation by inducing exopolysaccharide production in Acinetobacter oleivorans DR1

(2016) In-Ae Jang et al.   Scientific Reports

Effects of treatment with antimicrobial agents on the human colonic microflora

(2016) Fatemeh Rafii   Therapeutics and Clinical Risk Management

Acinetobacter baumannii Extracellular OXA-58 Is Primarily and Selectively Released via Outer Membrane Vesicles after Sec-Dependent Periplasmic Translocation

(2015) Yu-Ting Liao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Assessment of Minocycline and Polymyxin B Combination against Acinetobacter baumannii

(2015) Dana R. Bowers et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A PmrB-Regulated Deacetylase Required for Lipid A Modification and Polymyxin Resistance in Acinetobacter baumannii

(2015) Chui-Yoke Chin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Acinetobacter species as model microorganisms in environmental microbiology: current state and perspectives

(2015) Jaejoon Jung et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

In vitro activity of minocycline alone or in combination in multidrug-resistant Acinetobacter baumannii isolates

(2015) Carlos Hernan Rodríguez et al.   JOURNAL OF MEDICAL MICROBIOLOGY

White and blue light induce reduction in susceptibility to minocycline and tigecycline in Acinetobacter spp. and other bacteria of clinical importance

(2015) María Soledad Ramírez et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Homologs of the Acinetobacter baumannii AceI Transporter Represent a New Family of Bacterial Multidrug Efflux Systems

(2015) Karl A. Hassan et al.   mBio

Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia

(2015) Gul R. Yilmaz et al.   Journal of Infection in Developing Countries

Antibiotic Modulation of Capsular Exopolysaccharide and Virulence in Acinetobacter baumannii

(2015) Edward Geisinger et al.   PLoS Pathogens

Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens

(2015) Vishvanath Tiwari et al.   Frontiers in Microbiology

Efficacy of Sulbactam and Its Combination with Imipenem, Colistin and Tigecycline in an Experimental Model of Carbapenem-Resistant Acinetobacter baumannii Sepsis

(2014) Gokcen Dinc et al.   CHEMOTHERAPY

OXA  -Lactamases

(2014) B. A. Evans et al.   CLINICAL MICROBIOLOGY REVIEWS

Emergence of plasmid-mediated quinolone resistance genes in clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa in Henan, China

(2014) Xiaobing Jiang et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Comparison of colistin–carbapenem, colistin–sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections

(2014) A. Batirel et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Synergistic efficacy of meropenem and rifampicin in a murine model of sepsis caused by multidrug-resistant Acinetobacter baumannii

(2014) Yuan Sun et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Treatment option for sepsis in children in the era of antibiotic resistance

(2014) Irja Lutsar et al.   Expert Review of Anti-Infective Therapy

Molecular mechanisms of antibiotic resistance

(2014) Jessica M. A. Blair et al.   NATURE REVIEWS MICROBIOLOGY

Synergistic effect of Myrtus communis L. essential oils and conventional antibiotics against multi-drug resistant Acinetobacter baumannii wound isolates

(2014) Verica Aleksic et al.   PHYTOMEDICINE

Characterisation of Pellicles Formed by Acinetobacter baumannii at the Air-Liquid Interface

(2014) Yassine Nait Chabane et al.   PLoS One

Global Transcriptome and Physiological Responses of Acinetobacter oleivorans DR1 Exposed to Distinct Classes of Antibiotics

(2014) Aram Heo et al.   PLoS One

Synergistic effects of ethnomedicinal plants of Apocynaceae family and antibiotics against clinical isolates of Acinetobacter baumannii

(2014) Sasitorn Chusri et al.   Asian Pacific Journal of Tropical Medicine

Engineered Endolysin-Based "Artilysins" To Combat Multidrug-Resistant Gram-Negative Pathogens

(2014) Y. Briers et al.   mBio

RND-Type Efflux Pumps in Multidrug-Resistant Clinical Isolates of Acinetobacter baumannii: Major Role for AdeABC Overexpression and AdeRS Mutations

(2013) Eun-Jeong Yoon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroPharmacodynamics of Polymyxin B and Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii

(2013) Mao Hagihara et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synergistic Effects and Antibiofilm Properties of Chimeric Peptides against Multidrug-Resistant Acinetobacter baumannii Strains

(2013) Ramamourthy Gopal et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Experience of Colistin-Glycopeptide Combination in Critically Ill Patients Infected with Gram-Negative Bacteria

(2013) Nicola Petrosillo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis

(2013) Haiqing Chu et al.   Brazilian Journal of Infectious Diseases

Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial

(2013) Emanuele Durante-Mangoni et al.   CLINICAL INFECTIOUS DISEASES

Antimicrobial Resistance and Virulence: a Successful or Deleterious Association in the Bacterial World?

(2013) A. Beceiro et al.   CLINICAL MICROBIOLOGY REVIEWS

Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections

(2013) Y.-T. Lee et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens

(2013) Michael Hornsey et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Synergistic Antibacterial Activity of New Isomeric Carborane Derivatives Through Combination with Nanoscaled Titania

(2013) Shuihong Li et al.   Journal of Biomedical Nanotechnology

Insight into Norfloxacin Resistance of Acinetobacter oleivorans DR1: Target Gene Mutation, Persister, and RNA-Seq Analyses

(2013) Jisun Kim   JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY

Holarrhena antidysenterica as a resistance modifying agent against Acinetobacter baumannii: Its effects on bacterial outer membrane permeability and efflux pumps

(2013) Sasitorn Chusri et al.   MICROBIOLOGICAL RESEARCH

In vitro antibacterial activity of combinations of fosfomycin, minocycline and polymyxin B on pan-drug-resistant Acinetobacter baumannii

(2013) YAJUN ZHANG et al.   Experimental and Therapeutic Medicine

Characterization of bacterial biofilms formed on urinary catheters

(2012) Ryad Djeribi et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia

(2012) H. AYDEMIR et al.   EPIDEMIOLOGY AND INFECTION

Carbapenem-associated multidrug-resistant Acinetobacter baumannii are sensitised by aztreonam in combination with polyamines

(2012) Louis Malone et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

OmpA Is the Principal Nonspecific Slow Porin of Acinetobacter baumannii

(2012) E. Sugawara et al.   JOURNAL OF BACTERIOLOGY

Synergistic activity of coriander oil and conventional antibiotics against Acinetobacter baumannii

(2012) A. Duarte et al.   PHYTOMEDICINE

Isolation and Characterization of φkm18p, a Novel Lytic Phage with Therapeutic Potential against Extensively Drug Resistant Acinetobacter baumannii

(2012) Gwan-Han Shen et al.   PLoS One

Epidemiology, Clinical Characteristics and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Infections among Solid Organ Transplant Recipients

(2012) Ryan K. Shields et al.   PLoS One

The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace

(2012) Ignasi Roca et al.   Frontiers in Microbiology

Synergistic Combination of Chitosan Acetate with Nanoparticle Silver as a Topical Antimicrobial: Efficacy against Bacterial Burn Infections

(2011) Liyi Huang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Extended-Spectrum AmpC Cephalosporinase in Acinetobacter baumannii: ADC-56 Confers Resistance to Cefepime

(2011) Guo-Bao Tian et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Chitosan Augments Photodynamic Inactivation of Gram-Positive and Gram-Negative Bacteria

(2011) Tsuimin Tsai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VivoEfficacy of Glycopeptide-Colistin Combination Therapies in aGalleria mellonellaModel ofAcinetobacter baumanniiInfection

(2011) M. Hornsey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients

(2011) Wang Liang et al.   BMC INFECTIOUS DISEASES

High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen

(2011) Ryan K. Shields et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Characterization of theAcinetobacter baumanniigrowth phase-dependent and serum responsive transcriptomes

(2011) Anna C. Jacobs et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Genetic basis of antibiotic resistance in pathogenic Acinetobacter species

(2011) Laurent Poirel et al.   IUBMB LIFE

Evaluation of a DNA Microarray (Check-MDR CT102) for Rapid Detection of TEM, SHV, and CTX-M Extended-Spectrum  -Lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 Carbapenemases

(2011) T. Naas et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore

(2011) Tze-Peng Lim et al.   PLoS One

Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus–Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU)

(2011) Alexandr Nemec et al.   RESEARCH IN MICROBIOLOGY

In Vitro Double and Triple Bactericidal Activities of Doripenem, Polymyxin B, and Rifampin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli

(2010) C. Urban et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii

(2010) M. E. Pachon-Ibanez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Extended-Spectrum Cephalosporinase in Acinetobacter baumannii

(2010) J.-M. Rodriguez-Martinez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Potent Synergy and Sustained Bactericidal Activity of a Vancomycin-Colistin Combination versus Multidrug-Resistant Strains of Acinetobacter baumannii

(2010) N. C. Gordon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Overexpression of Resistance-Nodulation-Cell Division Pump AdeFGH Confers Multidrug Resistance in Acinetobacter baumannii

(2010) S. Coyne et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efflux-Mediated Antibiotic Resistance inAcinetobacterspp.

(2010) Sébastien Coyne et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Synergistic Action of Certain Combinations of Gentamicin and Essential Oils

(2010) A. Rosato et al.   CURRENT MEDICINAL CHEMISTRY

Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii

(2010) Glenn A. Pankuch et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Evolution of AbaR-type genomic resistance islands in multiply antibiotic-resistant Acinetobacter baumannii

(2010) V. Post et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India

(2010) K. Karthikeyan et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular and functional characterization of a novel efflux pump, AmvA, mediating antimicrobial and disinfectant resistance in Acinetobacter baumannii

(2010) Govindan Rajamohan et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Quantitative Proteomic Analysis of Cell Wall and Plasma Membrane Fractions from Multidrug-ResistantAcinetobacter baumannii

(2010) Sung-Ho Yun et al.   JOURNAL OF PROTEOME RESEARCH

Multidrug Resistance in Bacteria

(2009) Hiroshi Nikaido   Annual Review of Biochemistry

CraA, a Major Facilitator Superfamily Efflux Pump Associated with Chloramphenicol Resistance in Acinetobacter baumannii

(2009) I. Roca et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Role of AbeS, a Novel Efflux Pump of the SMR Family of Transporters, in Resistance to Antimicrobial Agents in Acinetobacter baumannii

(2009) V. B. Srinivasan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Acinetobacter baumannii Increases Tolerance to Antibiotics in Response to Monovalent Cations

(2009) M. I. Hood et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Role of reactive oxygen species in antibiotic action and resistance

(2009) Daniel J Dwyer et al.   CURRENT OPINION IN MICROBIOLOGY

Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

(2009) Matthew E. Falagas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Global spread of carbapenem-resistant Acinetobacter baumannii

(2009) P. G. Higgins et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The pgaABCD Locus of Acinetobacter baumannii Encodes the Production of Poly- -1-6-N-Acetylglucosamine, Which Is Critical for Biofilm Formation

(2009) A. H. K. Choi et al.   JOURNAL OF BACTERIOLOGY

Detection of blaOXA-58 and blaOXA-23-like genes in carbapenem-susceptible Acinetobacter clinical isolates: should we be concerned?

(2009) T. W. Boo et al.   JOURNAL OF MEDICAL MICROBIOLOGY